Evaluation of Patients in Chest Pain in the Emergency Room (EPIC-ER)
The primary objective of this feasibility study is to determine whether it is possible to conduct a study of the ClearView scan among patients under evaluation for acute cardiovascular events, as well as give insight into the performance of the ClearView scoring algorithm with respect to this patient population. The EPIC™ scan is a bio-electrographic tool that may assist the health care provider in rapid assessment of the systemic origin of the patient's presenting symptom(s). The EPIC ClearView is a potentially valuable resource that may benefit an emergency department (ED) by offering expedited "chest pain" etiologic differentiation capabilities. The subsequent results have the potential to include more rapid "chest pain" patient diagnosis and appropriate disposition of non-cardiac chest pain (rule out MI); optimized precious resource expenditure (nursing, physician, inpatient or observation bed, etc.); lower costs to facility, patient and insurance company; and greater patient satisfaction rates due to decreased ED wait time.
|Study Design:||Observational Model: Case-Only
Time Perspective: Cross-Sectional
|Official Title:||Evaluation of Patients in Chest Pain in the Emergency Room|
- Agreement of ClearView scan versus Active (Presenting) Diagnosis [ Time Frame: At time of study scan (Single study visit only, with no follow-up. The study endpoint will be reported for day 0, the day of the study visit.) ] [ Designated as safety issue: No ]Statistical agreement will be assessed between the 0-25 ClearView Response Scale and the presenting diagnosis/diagnoses for the Emergency Department admission recorded within the medical record, on a per-subject basis.
|Study Start Date:||May 2012|
|Estimated Primary Completion Date:||June 2013 (Final data collection date for primary outcome measure)|
Emergency Department Patients
Patients presenting to the Emergency Department complaining of chest pain.
Device: ClearView Scan
Assessment with ClearView device
Please refer to this study by its ClinicalTrials.gov identifier: NCT01476982
|United States, Arizona|
|Scottsdale Healthcare Shea Campus|
|Scottsdale, Arizona, United States, 85260|
|Scottsdale Healthcare Osborn Campus|
|Scottsdale, Arizona, United States, 85251|
|Principal Investigator:||Krishnaswami Vijayaraghavan, MD||Scottsdale Healthcare|